Left Menu
Development News Edition

Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet

Drug major Lupin on Wednesday announced the launch of its Favipiravir drug under the brand name 'Covihalt' for the treatment patients with mild to moderate COVID-19 symptoms at Rs 49 per tablet in India.

PTI | New Delhi | Updated: 05-08-2020 11:54 IST | Created: 05-08-2020 11:54 IST
Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet

Drug major Lupin on Wednesday announced the launch of its Favipiravir drug under the brand name 'Covihalt' for the treatment patients with mild to moderate COVID-19 symptoms at Rs 49 per tablet in India. Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use, Lupin said in a regulatory filing.

Its Covihalt dosage strength has been developed keeping in mind convenience of administration, it stated, adding that the drug is available as 200 mg tablets in the form of a strip of 10 tablets, and priced at Rs 49 per tablet. Lupin President - India Region Formulations (IRF) Rajeev Sibal said the company believes that it can leverage its expertise in managing widespread community diseases like tuberculosis to proactively reach patients across India and ensure access to Covihalt through its strong distribution network and field force.

On August 4, Sun Pharmaceutical Industries had launched Favipiravir under the brand name ''FluGuard'' for the treatment of mild to moderate cases of COVID-19, at Rs 35 per tablet in India. Shares of Lupin were trading 0.32 per cent higher at Rs 943.70 apiece on BSE.


TRENDING

OPINION / BLOG / INTERVIEW

Post-COVID-19 Nigeria needs a robust Health Management Information System to handle high disease burden

Nigeria is among a few countries that conceptualised a health management information system HMIS in the early 90s but implementation has been a challenge till date. Besides COVID-19, the country has a huge burden of communicable and non-com...

Morocco COVID-19 response: A fragile health system and the deteriorating situation

Learning from its European neighbors, Morocco imposed drastic measures from the initial stages of the COVID-19 outbreak to try to contain its spread. The strategy worked for a few months but the cases have surged after mid-June. In this sit...

COVID-19: Argentina’s health system inefficiencies exaggerate flaws of health information system

You can recover from a drop in the GDP, but you cant recover from death, was the straightforward mindset of Argentinas President Alberto Fernndez and defined the countrys response to COVID-19. The South American nation imposed a strict...

Rwanda’s COVID-19 response commendable but health information system needs improvement

Rwanda is consistently working to improve its health information system from many years. However, it is primarily dependent on the collection and reporting of health data on a monthly basis. Besides, evaluation studies on Rwandas HIS publis...

Videos

Latest News

Thai King endorses military's annual reshuffle

Thailands King Maha Vajiralongkorn has endorsed a new army chief from his own Kings Guard faction in an annual reshuffle of defence personnel, the government said in a statement on Friday.Armed forces reshuffles in Thailand are scrutinised ...

Several areas in Odisha likely to experience heavy rainfall: MeT

With a fresh low pressure area likely to form over Bay of Bengal around Sunday and trigger heavy rainfall in many parts of Odisha, the state government on Friday asked district administrations to remain prepared to deal with any flood like ...

Science News Roundup: First sea-based commercial satellite launch by China; World's largest fish are female and more

Following is a summary of current science news briefs.China sends satellites into space in the first sea-based commercial launchChina has successfully sent nine satellites into orbit in its first commercial launch of a rocket from a platfor...

Effective COVID-19 vaccine likely to be available by first quarter of 2021: Choubey

If the advanced clinical trials of COVID-19 vaccine succeed, then an effective vaccination is likely to be available by the end of first quarter of 2021, Minister of State for Health Ashwini Choubey informed Lok Sabha on Friday. He was resp...

Give Feedback